Lupin (NSE:LUPIN) Accounts Payable : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Lupin Accounts Payable?

Lupin's Accounts Payable for the quarter that ended in Dec. 2024 was ₹0 Mil.

Lupin's quarterly Accounts Payable increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹29,546 Mil) but then declined from Sep. 2024 (₹29,546 Mil) to Dec. 2024 (₹0 Mil).

Lupin's annual Accounts Payable increased from Mar. 2022 (₹22,829 Mil) to Mar. 2023 (₹25,315 Mil) and increased from Mar. 2023 (₹25,315 Mil) to Mar. 2024 (₹29,581 Mil).

Lupin Accounts Payable Historical Data

The historical data trend for Lupin's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Accounts Payable Chart

Lupin Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable

Get a 7-Day Free Trial

24,123.00

20,144.40

22,829.10

25,315.30

29,581.10

Lupin Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Payable	Get a 7-Day Free Trial															-	29,581.10	-	29,545.60	-

Lupin Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Lupin Accounts Payable Related Terms

Thank you for viewing the detailed overview of Lupin's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Lupin Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Accounts Payable

Traded in Other Exchanges

500257:India

Address

Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400055

Website

https://www.lupin.com

Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.

Lupin Headlines

No Headlines